Form 8-K - Current report:
SEC Accession No. 0001683168-26-004975
Filing Date
2026-06-18
Accepted
2026-06-18 16:33:43
Documents
13
Period of Report
2026-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 31821
2 OPINION OF POLSINELLI PC. sonoma_ex0501.htm EX-5.1 9118
6 GRAPHIC image_001.jpg GRAPHIC 2801
  Complete submission text file 0001683168-26-004975.txt   214095

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20260618.xsd EX-101.SCH 3026
4 XBRL LABEL FILE snoa-20260618_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE snoa-20260618_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3195
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 261103287
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)